Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 341 results found since Jan 2013.

E-Cig Popularity on the Rise
As states continue to pass laws that restrict the sale of e-cigarettes to minors, this post from 2013 explores why they've become so popular with teens. Good news! Cigarette smoking among American teenagers dropped to a record low in 2012. Not so good news—Many teens are turning to a new alternative known as “e-cigarettes.” What Are E-Cigarettes? Electronic cigarettes (e-cigs) are battery-operated products designed to deliver nicotine, flavor, and other chemicals as vapor that a user inhales, without producing actual tobacco smoke. A survey conducted by the Centers for Disease Control and Prevention found that the us...
Source: NIDA Drugs and Health Blog - July 9, 2014 Category: Addiction Authors: Sara Bellum Source Type: blogs

The FDA really caves: Stanislaw Burzynski can do clinical trials again
It’s hard for me to believe that it’s been almost three years since I first started taking an interest in the Houston cancer doctor and Polish expat Stanislaw Burzynski. Three long years, but that’s less than one-twelfth the time that Burzynski has been actually been administering an unproven cancer treatment known as antineoplastons (ANPs), a…
Source: Respectful Insolence - June 26, 2014 Category: Surgery Authors: Orac Tags: Bioethics Cancer Clinical trials Medicine Politics antineoplastons brain cancer fda Food and Drug Administration McKenzie Lowe Stanislaw Burzynski Terry Bennett Source Type: blogs

What’s the best skin lightening ingredient? The Beauty Brains Show episode 35
Do skin bleaching products really work? Are the ingredients safe? This week Randy and I explain everything you need to know about skin lightening.     Click below to play Episode 35 or click “download” to save the MP3 file to your computer. Show notes Beauty Science News: 7 ways to spot a real expert As you know we like to promote skeptical thinking, especially when it comes to beauty products. I found an interesting article from Forbes that gives 7 ways to tell you’re dealing with a real expert and not someone who’s just faking it. Real experts focus on their field, not themselves. Real experts hav...
Source: thebeautybrains.com - June 17, 2014 Category: Consumer Health News Authors: Perry RomanowskiThe Beauty Brains Tags: Best Podcast Problems Safety Source Type: blogs

Lung-MAP--A Bold Initiative To Find New Treatments For Squamous Cell Lung Cancer--Launches Today
Today marks a major step forward in cancer clinical trials and drug development with the launch of the Lung-MAP protocol to evaluate new treatments for squamous cell lung cancer, a common cancer which has proven resistant to the standard drugs currently available. In response to this genuine unmet need, Lung-MAP has been designed to move new therapies more quickly from the laboratory to the bedside of patients afflicted with this serious disease and few options available. Many--including present company--have written about the need to improve this process. We are in a new era of cancer drug development, spearheaded by our ...
Source: Dr. Len's Cancer Blog - June 16, 2014 Category: Cancer Authors: Dr. Len Tags: Access to care Cancer Care Lung Cancer Medications Research Tobacco Treatment Source Type: blogs

Oxytocin and Muscle Regeneration in Aging
Researchers have discovered an unexpected effect of oxytocin on muscle regeneration. One has to wonder just how much the fact that use of oxytocin is already approved by regulators factors into this work: there is a strong incentive for researchers to look for new marginal effects in the existing set of approved drugs and compounds rather than work on radically new and better medical technologies. This is because regulators impose vast costs on novel technologies, but only very large costs on reuse of existing treatments in new ways, and this structure percolates all the way back up the research chain due to its effects on...
Source: Fight Aging! - June 16, 2014 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

ASCO 2014 Is A Wrap: If Immunotherapy Is The Queen Of The Ball, Then Panomics Holds The Keys To The Kingdom
As in years past, the trip home from the Annual Meeting of the American Society of Clinical Oncology in Chicago gives me a moment to reflect on what I have heard and hopefully learned over the past five days. This meeting is a whirlwind of activity and information, far too much for any one person to absorb and process. You can be focused on one topic, you can be general, and you can hear new cutting edge research or be educated on topics of general interest in cancer. You can go to the exhibit hall and be overwhelmed by the booths and displays (I tend not to go there, but obviously many others do). I suspect you get the id...
Source: Dr. Len's Cancer Blog - June 4, 2014 Category: Cancer Authors: Dr. Len Tags: Access to care Breast Cancer Cancer Care Cervical Cancer Heatlh Information Technology Lung Cancer Media Medications Melanoma Other cancers Research Skin Cancer Treatment Source Type: blogs

The FDA Lays Down The Law About The Dangers Of Indoor Tanning
In what has to be considered a major victory for those concerned about the proliferating use and risks of tanning beds, the Food and Drug Administration this week issued a final rule requiring devices used for indoor tanning to meet very specific requirements before they can be marketed to the public. And in what is probably an even more important part of the rule, they now instruct those who market tanning devices to consumers to warn them clearly about the very real and serious risks of indoor tanning. What this means in plain terms is that if you use a tanning bed you will have to see a clearly defined boxed warning be...
Source: Dr. Len's Cancer Blog - May 29, 2014 Category: Cancer Authors: Dr. Len Tags: Early detection Environment Prevention Survivors Treatment Source Type: blogs

Cancer care for international patients
The world is a big place and here in the U.S., we are fortunate to live in a part of it where we have access to technology and advanced medical care, clinical trials, and new therapies, even before they are approved by the Food and Drug Administration. Indeed, even new agents approved for one indication can be prescribed off-label in this country. Continue reading ... Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - May 28, 2014 Category: Journals (General) Authors: Tags: Physician Cancer Source Type: blogs

Doubts Raised About Off-Label Use of Subsys, a Strong Painkiller - NYTimes.com
Almost overnight, a powerful new painkiller has become a $100 million business and a hot Wall Street story.But nearly as quickly, questions are emerging about how the drug is being sold, and to whom.The drug, Subsys, is a form of fentanyl, a narcotic that is often used when painkillers like morphine fail to provide relief. The product was approved in 2012 for a relatively small number of people — cancer patients — but has since become an outsize moneymaker for the obscure company that makes it, Insys Therapeutics. In the last year, the company's sales have soared and its share price has jumped nearly 270 percent.B...
Source: Psychology of Pain - May 14, 2014 Category: Psychiatrists and Psychologists Source Type: blogs

Abort, Retry, Fail? - Lancet Avoided Much Recent Unpleasantness in Reporting on New Gates Foundation CEO (Including Her Defense of $55,000 a Year for Bevacizumab)
The April 26, 2014 issue of the prestigious journal Lancet used two full pages and two separate articles by the same author to discuss the ascension of the Gates Foundation new CEO, Dr Susan Desmond-Hellmann.(1-2)Two Somewhat Redundant Lancet Articles Dr Desmond-Hellmann trained as an oncologist, spent time working on AIDS and Kaposi's Sarcoma in Uganda, but then spent much of her career as a pharmaceutical/ biotechnology executive, as described in the first article,(1)After returning from Uganda, Desmond-Hellmann joined the nascent Taxol development programme at Bristol-Myers Squibb, before being poached by Arthur Levinso...
Source: Health Care Renewal - May 5, 2014 Category: Health Management Tags: anechoic effect boards of directors conflicts of interest Gates Foundation Genentech health care foundations health care prices Lancet medical journals Procter and Gamble UCSF Source Type: blogs

A Five-Dimensional View of Pain | Pain Research Forum
Leaders of a major effort to systematically classify all common chronic pain conditions expect to have the first stage completed by mid-July 2014. The Pain Taxonomy, a project of the ACTTION public-private partnership, and the American Pain Society is one of two independent initiatives launched last spring to fill a widely perceived need for an updated evidence-based approach to improve diagnosis, treatment, and research of chronic pain (seePRF related news story). Key issues and decisions of the initial consensus meeting held in May 2013 are summed up in the March 2014 issue of The Journal of Pain. The paper also des...
Source: Psychology of Pain - April 8, 2014 Category: Psychiatrists and Psychologists Source Type: blogs

Please take a nanosecond to feel sorry for Myriad Genetics
They have become lawsuit happy. The Supreme court has said no company can hold the patent to a gene last summer. This means that Myriad Genetics has lost their monopoly, huge prices, and ability to strong arm the breast cancer population with their patent on the BRCA genes Okay that nanosecond is now long over. Now we can get on the road to reality. Myriad has decided that since they have lost their patent, their lawyers are going to get rich. They are in the "let's sue so we can keep our monopoly as long as possible"."Last week's ruling by Judge Shelby is perfectly clear about all that is at stake for Myriad: Although Pla...
Source: Caroline's Breast Cancer Blog - March 22, 2014 Category: Cancer Tags: change genetic testing laws personal protection personalized medicine Source Type: blogs

The Escalating Debate Over E-Cigarettes
Follow the bouncing ping-pong ball. “E-cigarettes are likely to be gateway devices for nicotine addiction among youth, opening up a whole new market for tobacco.”—Lauren Dutra, postdoctoral fellow at the UCSF Center for Tobacco Control Research and Education. “You’ve got two camps here: an abstinence-only camp that thinks anything related to tobacco should be outlawed, and those of us who say abstinence has failed, and that we have to take advantage of every opportunity with a reasonable prospect for harm reduction.”—Richard Carmona, former U.S. Surgeon General, now board member of e-cigarette maker NJOY.&nbs...
Source: Addiction Inbox - March 14, 2014 Category: Addiction Authors: Dirk Hanson Source Type: blogs

Las Vegas trial starts Monday in multibillion-dollar liability case against Actos
By CARRI GEER THEVENOTLAS VEGAS REVIEW-JOURNALTwo Clark County women are among thousands of plaintiffs across the country who have filed product liability lawsuits against the maker of the diabetes drug Actos.Delores Cipriano, 81, of Henderson and Bertha Triana, 80, of Las Vegas each filed lawsuits last year in District Court against Takeda Pharmaceuticals, a Japanese company that makes the prescription drug pioglitazone under the trade name Actos. Both women allege their bladder cancer was caused by the medication.Their cases have been combined, and their lawyers are scheduled to present opening statements to a jury this ...
Source: PharmaGossip - March 10, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Patient Informed Consent from Partially Uniformed Physicians
The title of this thread clearly sets the topic to be discussed.  Informed consent by a patient for an examination or medical-surgical procedure is an established ethical and legal act which has been even more focused throughout the medical profession in the recent decades when previous professional paternalism behavior dissolved to patient autonomy.  However established the practice is preached, the act still depends on several factors. With regard to the patient becoming informed about the details of the examination and procedure, it requires the patient or patient's surrogate making a decision to comprehend wh...
Source: Bioethics Discussion Blog - March 6, 2014 Category: Health Medicine and Bioethics Commentators Source Type: blogs